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Objective: To investigate the epidemiobgical characteristics of the elder-
ly with atrial fibrillation (AF) in age, gender, the types of AF and relative 
causes. And To analyze the risk factors of persistent AF (PeAF), then use 
them to guide to prevent and treat for AF in the elderly.Methods: Col-
lect the data of elderly patients with AF who were admitted to Liaoning 
People's Hospital from September 1, 2016 to September 30, 2017, and 
summarize the epidemiological characteristics of AF in the elderly. The 
risk factors for PeAF were analyzed by Spearman correlation analysis 
and mltivariate logistic regression analysis. Result: 1. In the elderly, the 
number of AF cases increase with age. The group of 75-84 years old was 
the largest part. The number of older females was larger than male in all 
ages. It was important to pay more attention to old woman with AF. 2.In 
the elderly, nonvalvular atrial fibrillation is popular. The top three causes 
of AF in the elderly were CHD, hypertension and heart failure. In the 
elderly, comorbidities were frequent, and the management was a major 
therapeutic objective. 3.CRP, 1eft atria diameter were the independent 
risk factors for PeAF in the elderly.
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1. Introduction
Atrial fibrillation (AF), as one of the most common tachyarrhythmias, is currently affecting 33 mil-lion people worldwide and growing at an annual 
rate of 5 million[1]. It is known as the "Cardiovascular 
Epidemiology in the 21st Century”. Some reports showed 
that there are about 2.7 million to 6.7 million people with 
AF in the United States; and it is estimated that it will in-
crease to 5.6 million to 15.9 million people by 2050[2,3]. In 
2010, studies showed that about 8.8 million elderly people 
over 55 years of age in Europe suffered from AF. If the 
age and sex ratio remained stable, the number of people 
with AF is expected to double by 2060[4]. By 2050, there 
will be 7.2 million patients with AF and 2.9 million pa-
tients with atrial fibrillation-related stroke in Asia[5]. Most 
of the patients with AF are the elderly, and the incidence 
of AF increases with age. The Framingham study showed 
that the incidence of AF increased significantly after the 
age of 60, doubling on average every 10 years[6]; In 2004, 
Zhou et al. carried out a large-scale epidemiological study 
on 29079 cases of 14 natural populations. Among them, 
224 patients with AF had a standardized prevalence rate 
of 0.61%, 0.5% in people aged 50-59, and 7.5% in those 
aged over 80[7]. Many studies have shown that the inci-
dence of AF increases with age. Most of the patients are 
over 60 years old. Researchers suggest that AF research 
should be carried out for people over 60 years old.
16
Journal of Geriatric Medicine | Volume 01 | Issue 01 | April 2019
Distributed under creative commons license 4.0
In the special group of the elderly, AF often coexists 
with a variety of diseases, showing a comorbid state, and 
mutual influence, mutual cause and effect. The occurrence 
of AF is often associated with many organic cardiovascu-
lar diseases, such as coronary heart disease, hypertension, 
heart failure, valvular disease, cardiomyopathy, sick sinus 
syndrome, etc., and is also closely related to other sys-
temic diseases, such as hyperthyroidism, diabetes, sleep 
apnea syndrome, ischemic stroke, chronic kidney disease, 
etc. AF not only affects the quality of life of patients, but 
also significantly increases the risk of heart failure and 
stroke[8].
With the continuous progress of the aging of the social 
population, the number of patients with AF is also increas-
ing. AF and aging are unavoidable medical and social 
problems all over the world, which is of great significance 
to conduct the in-depth study on AF in the elderly. At 
present, the treatment of AF is the research focus of most 
scholars, radiofrequency ablation of AF, left atrial ap-
pendage occlusion, pacemaker therapy and other diverse 
treatments. The cost of clinical treatment is high; the risk 
factors of intervention in AF can reduce the burden of AF 
to a certain extent. The occurrence of AF varies in differ-
ent races and regions. According to the AHA/ACC/HRS 
guidelines for AF management in 2014, approximately 
35% of patients with AF are older than 80 years old. In 
most atrial fibrillation-related studies, the selection con-
ditions of the subjects are relatively broad and there is no 
specific age limit. As a result, the average age of the study 
cohort is about 5 years younger than that of the popula-
tion with AF. Whether these findings are applicable to the 
elderly is still controversial[9]. Therefore, it is necessary 
to carry out relevant researches on the elderly with AF. 
This study was conducted in a single-center retrospective 
analysis of 700 elderly patients with AF who were over 
65 years old and hospitalized in Liaoning People's Hos-
pital. The clinical characteristics of elderly patients with 
AF were summarized, including age, sex, type of AF and 
related etiology. The related risk factors of elderly patients 
with persistent AF were analyzed to provide direction and 
reference for the prevention and treatment of elderly pa-
tients with AF.
2. Materials and Methods
2.1 Research Subjects 
The medical records of elderly patients with atrial fibril-
lation who were admitted to the Heart Center of Liaoning 
People's Hospital from September 1, 2016 to September 
30, 2017 were counted. Included subjects: Patients aged 
65 years or older with evidences of AF such as electrocar-
diogram or dynamic electrocardiogram or a clear history 
of AF. Excluded subjects: Patients with transient/reversible 
etiology. These include acute myocardial infarction, acute 
myocarditis, untreated hyperthyroidism and AF caused by 
recent electrophysiological examinations, angiography, 
pacemaker surgery, and cardiothoracic surgery, etc. The 
data of multiple hospitalized patients were based on the first 
hospitalization data and were counted only once.
2.2 Methods
2.2.1 Clinical Data Collection
It should be include patient age, gender, etiology and 
type of AF, past medical history, and related laboratory in-
dicators, i.e., C-reactive protein (CRD), triglyceride (TG), 
cholesterol (TC), low-density lipoprotein (LDL), blood 
uric acid (BUA), serum creatinine (CREA) and so on, 
echocardiography recorded left atrial meridian (LAD), left 
ventricular ejection fractions(LVEF%).
2.2.2 Diagnostic Criteria for Major Diseases
(1) Elderly: age over 65
(2) Diagnostic criteria for atrial fibrillation: A. At least 
one ECG or 24 hour dynamic electrocardiogram (DCG) 
proved the diagnosis of AF.  B. A clear history of 
atrial fibrillation in the past. At least one of them should 
be met.
(3) Type of AF:
A. Paroxysmal atrial fibrillation: a kind of AF with a 
duration of <7 days, which can be converted within 48 
hours, with self-limiting.
B. Persistent atrial fibrillation: a kind of AF with a du-
ration of >7 days, which cannot be converted by itself.
C. Valvular atrial fibrillation: heart valve disease di-
agnosed by echocardiography, combined with AF. Heart 
valve diseases include rheumatic heart disease, senile de-
generative valvular disease.
D. Non-valvular atrial fibrillation: exclusion of valvu-
lar heart disease by echocardiography, with other diseases 
such as coronary heart disease, cardiomyopathy, pulmo-
nary heart disease, congenital heart disease, hypertension, 
hyperthyroidism, electrolyte imbalance, anemia, com-
bined with AF.
E. Isolated atrial fibrillation: Clinical examination 
confirmed no combined heart disease such as coronary 
heart disease, cardiomyopathy, pulmonary heart disease, 
congenital heart disease, and other systemic diseases such 
as hypertension, hyperthyroidism, electrolyte imbalance, 
anemia, combined with AF.
(4) Cardiomyopathy: mainly including dilated cardio-
myopathy, hypertrophic cardiomyopathy, etc.
DOI: https://doi.org/10.30564/jgr.v1i01.735
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(5) Hypertension: according to the 2010 Guidelines for 
the Prevention and Treatment of Hypertension in China, 
patients with systolic blood pressure(≥ 140 mm Hg) and/
or diastolic blood pressure (≥ 90 mm Hg), or who have 
previously diagnosed hypertension, who are receiving an-
tihypertensive therapy and whose blood pressure level is 
within the normal range .
(6) Diagnostic criteria for heart failure: class II and 
above of cardiac function were diagnosed as heart failure 
according to the cardiac function classification of the New 
York Heart Association (NYHA). 
(7) Diagnostic criteria for diabetes: using the diagnostic 
criteria proposed by the American Diabetes Association 
in 2012, i.e., fasting blood glucose ≥ 7.0 mmol/L and/or 
OGTT test was ≥11.1 mmol/L. Or a definite diagnosis of 
diabetes in the past.
(8) Diagnostic criteria for coronary heart disease: A. 
previous history of angina pectoris or significant ST-T 
changes showed by electrocardiogram, 24-hour DCG, ex-
ercise plate test, etc., during hospitalization; B. coronary 
artery stenosis (≥ 50%) confirmed by coronary angiogra-
phy; C. history of acute myocardial infarction or previous 
definite history of myocardial infarction. One of the above 
conditions should be met.
2.2.3 Cases Grouping
(1) 2 groups by gender: male and female.
(2) 3 groups by age: 65 to 74 years old, 75 to 84 years 
old, 85 years old and above.
(3) 2 groups according to the type of AF: A. Paroxys-
mal atrial fibrillation and persistent atrial fibrillation; B. 
valvular atrial fibrillation and non-valvular atrial fibrilla-
tion.
2.2.4 Statistical Methods
SPSS 18.0 program was used for statistical data pro-
cessing; Chi-square test selected for counting data; t test 
selected for measurement data; P<0.05 was statistically 
significant. Spearman correlation analysis was used for 
statistical significance indicators, and logistic regression 
analysis was conducted for correlative indicators.
3. Results
3.1 Clinical Features of Elderly Atrial Fibrillation
A total of 1144 patients with AF in the Hear Center of our 
hospital, from September 1st, 2016 to September 30th, 
2017, were diagnosed as AF. According to the inclusion 
and exclusion criteria, 700 elderly patients with AF were 
enrolled, ranging in age from 65 to 99-year-old, with an 
average age of 77.1±6.9 years, accounting for 61.2% of 
all patients with AF. There were 316 male patients (45.1%) 
and 384 female patients (54.9%). The ratio of male to fe-
male was approximately 1:1.2.
3.1.1 Age and Gender Distribution
In the elderly population, the proportion of AF increased 
with age. The highest proportion of AF occurs in the 75-
84 age group (49.9%) (Table 1). According to age, there 
were more female patients than male patients among dif-
ferent age groups. According to gender, the proportion of 
75-84 years old group was the highest in both male and 
female patients. The chi-square test was performed ac-
cording to the X-list. There was no significant difference 
between the groups (P<0.05).
Table 1. Statistics of age and gender
Age Male Female Total
65-74 110 132 242
75-84 156 193 349
85 and above 50 59 109
Total 316 384 700
3.1.2 Relevant etiological statistics
The causes and related factors of 700 elderly patients with 
AF were analyzed. As shown in figure 1, 481 cases (68.7%) 
of coronary heart disease, 406 cases (58.0%) of hyperten-
sion, 341 cases (48.7%) of heart failure, 191 cases (27.3%) 
of diabetes, 105 cases (15.0%) of valvular disease, 25 
cases (3.6%) of cardiomyopathy, 21 cases (3.0%) of sick 
sinus syndrome and 20 cases (2.9%) of pulmonary heart 
disease, 15 cases (2.1%) of isolated atrial fibrillation and 
2 cases (0.3%) of congenital heart disease were included. 
Among them, 41 cases were rheumatic valvular disease, 
accounting for 39.0% of valvular disease, accounting for 
5.9% of the total number; 19 cases were senile valvular 
disease, accounting for 18.1% of valvular disease, ac-
counting for 2.7% of the total number.
Figure 1. Analysis of the causes and related factors of 700 
elderly patients with AF
DOI: https://doi.org/10.30564/jgr.v1i01.735
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3.1.3 Type distribution of atrial fibrillation
Among 700 patients with atrial fibrillation, according 
to the causes, there were 595 patients with non-valvular 
atrial fibrillation, accounting for 85.0% of the total num-
ber, including 271 male patients and 324 female patients. 
There were 105 patients with atrial fibrillation, including 
45 male patients and 60 female patients. Both types of AF 
were more common in women; and non-valvular atrial 
fibrillation was common in both male and female patients. 
There was no significant difference between them (P > 
0.05).
According to the duration of onset, 314 cases of parox-
ysmal atrial fibrillation, accounting for 44.9% of the total 
number, including 134 males and 180 females; 386 cases 
of persistent atrial fibrillation, accounting for 55.1% of the 
total number, including 182 males and 204 females. There 
was no significant difference between the type of atrial 
fibrillation and gender composition (P>0.05).
3.2 Risk Factors Associated with Persistent Atrial 
Fibrillation in the Elderly
3.2.1 Comparison of Observation Indexes be-
tween Paroxysmal Atrial Fibrillation and Per-
sistent Atrial Fibrillation
The general clinical data between the two groups were 
compared. As shown in Table 2, Patients in the persistent 
atrial fibrillation group was older than those in the par-
oxysmal atrial fibrillation group; and the proportion of 
patients aged ≥75 years was higher. The proportion of 
patients’ persistent atrial fibrillation combined with hy-
pertension, diabetes, coronary heart disease, heart failure, 
valvular disease and ischemic stroke were higher. Among 
them, there were significant differences in age, hyperten-
sion, heart failure and valvular disease (P < 0.05), and no 
significant differences in other items (P > 0.05). The two 
groups of laboratory tests and cardiac color Doppler ultra-
sound indicators were compared, as shown in Table 3. In 
the persistent atrial fibrillation group, the levels of CRP, 
BUA, left atrial inner diameter were higher, and LVEF 
was lower. There were significant differences in CRP, 
uric acid, left atrial diameter and LVEF between the two 
groups (P < 0.05). There was no significant difference in 
the other indexes between the two groups (P > 0.05).
Table 2: Comparison of general medical records
Paroxysmal atrial 
fibrillation
(n = 314)
Persistent atrial 
fibrillation
(n = 386)
Statistic 
value P value
Age 75.81±6.58 78.25±6.96 t =4.728 0.000
≥75 years old 185 274 x2=11169 0.001
Hypertension 
(cases) 196 210 x
2=4.568 0.033
Diabetes (cas-
es) 86 105 x
2=0.003 0.956
Coronary 
heart disease 
(cases)
226 255 x2=2.815 0.093
Heart failure 
(cases) 108 233 x
2=46.734 0.000
Valvular dis-
ease (cases) 14 91 x
2=49.628 0.000
Ischemic 
stroke (cases) 85 99 x
2=0.181 0.671
Table 3. Comparison of laboratory and cardiac ultrasound 
indicators
Paroxysmal atrial 
fibrillation
(n = 314)
Persistent atrial 
fibrillation
(n = 386)
Statistic value P value
CRP (mg/L) 815±2.65 18.15±5.95 t = -27.642 0.000
UA (μmol/L) 355.06±94.94 379.26±108.21 t = -3.108 0.002
Creatinine 
(μmol/L) 98.35±25.52 99.45±23.14 t = -0.596 0.551
TC (mmol/L) 3.93±0.92 3.91±0.89 t = 0.386 0.699
TG (mmol/L) 1.19±0.34 1.24±0.39 t = -1.572 0.116
LDL (mmol/L) 2.38±0.59 2.41±0.85 t = -0.486 0.627
Left atrial 
inner diameter 
(mm)
37.54±5.40 51.01±7.71 t = -5.053 0.000
LVEF(%) 53.68±7.04 47.53±4.75 t = -13.734 0.000
3.2.2 Spearman Correlation Analysis
Spearman correlation analysis was performed on the 
above eight statistically significant items, as shown in Ta-
ble 4. The results showed that persistent atrial fibrillation 
was positively correlated with age, heart failure, valvular 
disease, CRP, uric acid, and left atrial diameter; and nega-
tively correlated with LVEF, but not with hypertension.
Table 4. Spearman correlation analysis
r value P value
Age 0.181 0.000
Hypertension -0.055 0.146
Heart failure 0.262 0.000
Valvular disease 0.266 0.000
CRP 0.820 0.000
Uric acid 0.166 0.000
Left atrial diameter 0.167 0.000
LVEF -0.477 0.000
3.2.3 Multivariate Logistic Regression Analysis
Multivariate logistic regression analysis was performed 
on relevant 7 items including age, CRP, uric acid, left 
DOI: https://doi.org/10.30564/jgr.v1i01.735
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atrial diameter, LVEF, heart failure, and valvular disease. 
The results showed that CRP level and left atrial inner 
diameter were independent risk factors for persistent atrial 
fibrillation in the elderly.
4. Discussion
4.1 Clinical Characteristics of Atrial Fibrillation 
in the Elderly
4.1.1 Age
Many studies have confirmed that age is an indepen-
dent risk factor for atrial fibrillation, and is now widely 
recognized. Patients with atrial fibrillation aged 65 and 
over are specifically referred to as atrial fibrillation in 
the elderly[10]. The incidence of AF increases with age. 
The Framingham study showed that the incidence of AF 
was 0.5% in the 50-59 age group, 1.8% in the 60-69 age 
group, 4.8% in the 70-79 age group, and 8.8% in the 80-
89 age group. The incidence of AF increased significantly 
after 60 years old, with an average annual increase of 1 
fold[6]. According to a study published by the EHRA (Eu-
ropean Heart Rhythm Association), the prevalence of AF 
in people younger than 60 years is about 1%; the preva-
lence of people aged 75-84 years is increased to 12%, and 
more than 1/3 after 80 years old[11]. The expert consensus 
of FSGG/FSC (French Society of Gerontology and Geri-
atrics/French Society of Cardiology) in 2013 pointed out 
that 70% of patients with AF are older than or equal to 75 
years old [12]. At present, there is a lack of large-scale atrial 
fibrillation data statistics in China. In 2004, Zhou et al. 
carried out a large-scale epidemiological study on 29079 
cases of 14 natural populations. Among them, the preva-
lence rate was 0.5% in the 50-59 age group, and 7.5% in 
the 80-year-old group[7]. 
The results of this study showed that in elderly patients 
with AF, patients over 75 years of age were the main pa-
tient group. This is consistent with the above findings. 
Patients aged 75-84 accounted for the majority of patients. 
Compared with that, the proportion of patients over 85 
years of age did not increase significantly, which may be 
related to the small number of elderly hospitalized, popu-
lation, regional differences and other factors.
The prevalence rate of AF increases with age; and it 
occurs more frequently in the elderly, which is associat-
ed with a series of body changes caused by aging. It has 
been suggested in the literature that when the human body 
enters the aging stage and develops further with the aging 
degree, the expression of L-type calcium channels and 
contractile proteins decreases at the gene and protein lev-
els, and the left atrium (LA) may become more prominent 
in the occurrence and development of AF. The specific 
reasons and possible mechanisms are not fully known and 
determined yet, which needs to be further studied[13].
4.1.2 Gender
The 38-year follow-up study of Framingham[6] in the 
United States showed that the prevalence of AF in men 
was 1-5 times higher than that in women. Studies in Chi-
na have shown that the incidence of male AF is slightly 
higher than that of females[7,14]. But other studies have 
suggested further points. Feinberg et al. showed that male 
patients are more common than female patients before the 
age of 75; and after 75 years old, the proportion of female 
patients with atrial fibrillation increased, which was about 
60%[15]. Other studies have shown that the prevalence 
of women in the age group >75 years old is twice that 
of men [16]. According to statistics from Switzerland, the 
prevalence of atrial fibrillation among women under 80 
is lower than that of men, and women over 80 are higher 
than men [17]. In 2015, a study showed that the incidence 
of atrial fibrillation in China was 0. 05/100 patients · year. 
After age adjustment, the incidence and prevalence of 
atrial fibrillation in women were lower than in men, but 
the prevalence of atrial fibrillation in elderly women in-
creased significantly [18]. This suggests that gender differ-
ences in atrial fibrillation may vary with age. The results 
of this study indicate that the prevalence of atrial fibrilla-
tion in older women is higher than that in men. The male 
to female ratio is about 1:1.2, and the prevalence of wom-
en in all age groups is high, which is roughly consistent 
with the above findings. The higher prevalence of atrial 
fibrillation in older women may be associated with chang-
es in estrogen levels, autonomic dysfunction, increased 
risk factors for comorbidity in older women, and longer 
life expectancy in women. The specific reasons still need 
further discussion. Patients with atrial fibrillation have a 
faster ventricular rate and more pronounced symptoms. 
Compared with men, the quality of life is lower, and the 
mortality rate of female atrial fibrillation is not lower than 
that of men [19-21].
4.2 Risk Factors Associated with Persistent Atrial 
Fibrillation
4.2.1 Atrial Fibrillation and Heart Failure
In the American Flemingham study, the annual incidence 
of atrial fibrillation in heart failure patients was 54%, and 
the annual incidence of central dysfunction in patients 
with atrial fibrillation was 33% [22]. Atrial fibrillation in-
teracts with heart failure. They have common risk factors 
such as age, smoking, obesity, hypertension, diabetes, 
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renal impairment, valvular heart disease, coronary artery 
disease, and obstructive sleep apnea. Pathophysiological 
mechanisms, neuroendocrine, electrophysiological and 
hemodynamic changes promote each other and form a 
vicious cycle [23]. Diastolic heart failure is common in the 
elderly population, and the incidence of arrhythmia is 
significantly higher than that of systolic heart failure. The 
results of this study suggest that heart failure is closely as-
sociated with persistent atrial fibrillation in the elderly. In-
creased volume load in patients with heart failure can lead 
to atrial dilatation, atrial stretch can activate ion channels, 
abnormal cardiac conduction, shortened refractory period 
and other changes, and increased blood volume can acti-
vate RASS system, which is conducive to the maintenance 
of atrial fibrillation. Meanwhile, the application of digoxin 
and other drugs has a certain impact on the progress of 
atrial fibrillation. In the later stage, the effects of heart 
function grading and anti-heart failure medication on per-
sistent atrial fibrillation can be further studied.
4.2.2 Atrial Fibrillation and Hypertension
Hypertension is an independent predictor of newly onset 
atrial fibrillation and is almost linearly correlated with 
the occurrence of atrial fibrillation. Meanwhile, multi-
ple studies have confirmed that prehypertension is also 
a high-risk factor related to atrial fibrillation [24-26]. Most 
old people have arteriosclerosis, and the difference in 
pulse pressure is large. Foreign studies suggest that an in-
crease of 20mmHg in pulse pressure can increase the risk 
of atrial fibrillation [27]. Studies on elderly patients with 
hypertension have found a certain correlation between 
non-arytenoid blood pressure and the occurrence of atrial 
fibrillation [28]. It is suggested that reducing blood pressure 
variability in hypertensive patients can reduce the recur-
rence of atrial fibrillation and related target organ damage. 
Meanwhile, other scholars have put forward different 
conclusions. A meta-analysis conducted by Webb et al. 
pointed out that the blood pressure variability in patients 
with hypertension did not reduce the risk of new atrial 
fibrillation [29]. Blood pressure variability can be used as a 
predictor of risk, but may not be suitable as a therapeutic 
target. Whether it is an independent risk factor for atrial 
fibrillation needs further study. In this study, hypertension 
was associated with persistent atrial fibrillation. The left 
atrial structure changes induced by chronic hypertension 
provide conditions for the maintenance of atrial fibril-
lation. The vascular endothelium is damaged by hyper-
tension, which further leads to atherosclerosis. Increased 
arterial stiffness is characterized by increased pulse differ-
ential pressure, which increases the risk of atrial fibrilla-
tion. In this study, the relationship between hypertension 
and atrial fibrillation was not further studied in terms of 
grading of hypertension and pulse pressure, which is the 
deficiency of this study.
5. Conclusion
(1) In elderly patients with atrial fibrillation, the pro-
portion of atrial fibrillation increases with age. The age 
group between 75 and 84 years old accounted for the larg-
est proportion, and the proportion of elderly women pa-
tients was higher, and slightly higher than that of men in 
all age groups. Elderly women with atrial fibrillation need 
to be taken seriously.
(2) Non-valvular atrial fibrillation is most common in 
elderly patients with atrial fibrillation. The most common 
first three related causes or risk factors are coronary heart 
disease, hypertension, and heart failure. The comorbidity 
of elderly patients with atrial fibrillation is common, and 
comorbid management is the prevention and treatment 
target of atrial fibrillation in the elderly.
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